中华神经医学杂志
中華神經醫學雜誌
중화신경의학잡지
CHINESE JOURNAL OF NEUROMEDICINE
2014年
5期
499-503
,共5页
黄从刚%卞红强%罗正利%段栩飞%杨俊%黄茂华%刘智胜%陈谦学
黃從剛%卞紅彊%囉正利%段栩飛%楊俊%黃茂華%劉智勝%陳謙學
황종강%변홍강%라정리%단허비%양준%황무화%류지성%진겸학
左乙拉西坦%托吡酯%癫痫%随机对照试验%系统评价
左乙拉西坦%託吡酯%癲癇%隨機對照試驗%繫統評價
좌을랍서탄%탁필지%전간%수궤대조시험%계통평개
Levetiracetam%Topiramate%Epilepsy%Randomized controlled trial%Systematic review
目的 系统评价左乙拉西坦(LEV)和托吡酯(TPM)治疗癫痫的临床疗效与安全性.方法 计算机检索2003~2013年Cochrane图书馆、PubMed、EMBASE、SCIE数据库和中国生物医学文献数据库、中国全文期刊数据库、中国知网、万方数据库收录的LEV、TPM治疗癫痫的相关文献,筛选随机对照试验(RCT),提取资料进行质量评价并采用RevMan 5.0软件进行Meta分析.结果 共纳入6个RCT,包括1588例病例,其中LEV组648例、TPM组940例.Meta分析表明LEV组与TMP组患者用药后总体有效率的比较差异无统计学意义(OR=0.82,95%CI:0.63~1.07,P=0.150);TMP组认知障碍发生明显高于LEV组,差异有统计学意义(OR=0.73,95%CI:0.56~0.94,P=0.020). 结论 在癫痫临床用药治疗过程中,LEV和TPM的总体疗效相当,但TPM对癫痫患者认知障碍损害的发生几率高于LEV,安全性较低.
目的 繫統評價左乙拉西坦(LEV)和託吡酯(TPM)治療癲癇的臨床療效與安全性.方法 計算機檢索2003~2013年Cochrane圖書館、PubMed、EMBASE、SCIE數據庫和中國生物醫學文獻數據庫、中國全文期刊數據庫、中國知網、萬方數據庫收錄的LEV、TPM治療癲癇的相關文獻,篩選隨機對照試驗(RCT),提取資料進行質量評價併採用RevMan 5.0軟件進行Meta分析.結果 共納入6箇RCT,包括1588例病例,其中LEV組648例、TPM組940例.Meta分析錶明LEV組與TMP組患者用藥後總體有效率的比較差異無統計學意義(OR=0.82,95%CI:0.63~1.07,P=0.150);TMP組認知障礙髮生明顯高于LEV組,差異有統計學意義(OR=0.73,95%CI:0.56~0.94,P=0.020). 結論 在癲癇臨床用藥治療過程中,LEV和TPM的總體療效相噹,但TPM對癲癇患者認知障礙損害的髮生幾率高于LEV,安全性較低.
목적 계통평개좌을랍서탄(LEV)화탁필지(TPM)치료전간적림상료효여안전성.방법 계산궤검색2003~2013년Cochrane도서관、PubMed、EMBASE、SCIE수거고화중국생물의학문헌수거고、중국전문기간수거고、중국지망、만방수거고수록적LEV、TPM치료전간적상관문헌,사선수궤대조시험(RCT),제취자료진행질량평개병채용RevMan 5.0연건진행Meta분석.결과 공납입6개RCT,포괄1588례병례,기중LEV조648례、TPM조940례.Meta분석표명LEV조여TMP조환자용약후총체유효솔적비교차이무통계학의의(OR=0.82,95%CI:0.63~1.07,P=0.150);TMP조인지장애발생명현고우LEV조,차이유통계학의의(OR=0.73,95%CI:0.56~0.94,P=0.020). 결론 재전간림상용약치료과정중,LEV화TPM적총체료효상당,단TPM대전간환자인지장애손해적발생궤솔고우LEV,안전성교저.
Objective To evaluate the clinical treatment efficacy and safety of levetiracetam (LEV) versus topiramate (TPM) in epilepsy.Methods Cochrane Database of Systematic Reviews,EMbase,PubMed,SCIE,CNKI,Chinese periodical full-text database,Chinese Biomedical Literature Database and Wanfang Database were used to select the related literature about epilepsy treated with levetiracetam and topiramate published from 2003 to 2013; randomized controlled trials (RCTs) were selected.The Cochrane Collaboration RevMan5.0 software was used for data analysis.Results Six RCTs involving 1588 patients were included with all trials published in English,among which 648 accepted LEV treatment and 940 accepted TPM treatment.Meta analysis results showed no statistically significant differences on the total effective rate between the TEV and TMP treatment groups (OR=0.82,95%CI=[0.63-1.07],P=0.150).But there were differences on cognitive disorders between the two groups (OR=0.73,95%CI=[0.56-0.94],P=0.020).Conclusion It seems that LEV and TPM have equal efficacy in the clinical medication treatment for epilepsy; however,LEV treatment has higher risk of causing cognitive abnormalities than TPM treatment.